Clinical trial
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and…
NCT00320619 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00320619 |
|---|---|
| Title | Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery |
| Official title | Aminocaproic Acid and Bleeding in Spinal Surgery |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Scoliosis, Kyphosis, Lordosis, Spondylitis, Spinal Stenosis |
| Intervention type | Drug |
| Interventions | Epsilon-Aminocaproic Acid (EACA), Placebo |
| Enrollment | 182 |
| Start date | Sep 1, 2000 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | May 3, 2006 |
| Last update posted | Jul 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: